Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)

v3.21.2
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Revenues $ 691 $ 823 $ 15,191 $ 1,432
Cost of revenues 429 748 1,315 1,223
Gross Profit 262 75 13,876 209
Operating expenses:        
Research and development 1,901 1,002 3,534 1,812
General, administrative and marketing 1,424 986 3,379 2,017
Operating income (loss) (3,063) (1,913) 6,963 (3,620)
Financial income 72 9 122 26
Financial expenses (8) (2) (27) (6)
Exchange differences (39) (65) 28 28
Financial income (expenses), net 25 (58) 123 48
Net income (loss) for the period $ (3,038) $ (1,971) $ 7,086 $ (3,572)
Basic net income (loss) per ordinary share (in Dollars per share) $ (0.3) $ (0.28) $ 0.76 $ (0.52)
Diluted net income (loss) per ordinary share (in Dollars per share) $ (0.3) $ (0.28) $ 0.58 $ (0.52)
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares) 10,201,231 6,958,109 9,315,817 6,809,666
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares) 10,201,231 6,958,109 12,173,715 6,809,666